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CHAPTER 1. INTRODUCTION 
Objective 
Enzyme linked immunosorbant assays (ELISAs) are commonly used for monitoring 
herd infection and diagnosing infection by Mycoplasma hyopneumoniae in individual pigs. 
There is relatively little information in the scientific literature addressing the performance 
and characteristics of M. hyopneumoniae ELISAs. The overall objective of the studies 
reported here was to evaluate the performance of these tests. 
Thesis Organization 
This thesis consists of a general introduction, literature review, two chapters 
representing research submitted for publication and a general summary. 
Statement of the Problem 
There are currently several commercially available ELISAs for the detection of M 
hyopneumoniae antibodies. These ELISAs are based on detection of antibodies to M 
hyopneumoniae in swine serum. Unfortunately, because M. hyopneumoniae attaches to the 
ciliated respiratory epithelium and is minimally invasive, the serum antibody response 
following infection can be variable. This variable antibody response makes interpretation of 
assay results difficult, especially due to a high percentage of false negative test results. 
2 
Accordingly, the relationship of ELISA results to the presence or absence of M. 
hyopneumoniae infection has been controversial. Although ELISAs for detection of M 
hyopneumoniae antibodies are used extensively, there is little information in the scientific 
literature as to the performance attributes (i.e. sensitivity, specificity, positive predictive 
value, negative predictive value, etc.) of these tests. 
3 
CHAPTER 2. LITERATURE REVIEW 
Introduction 
Mycoplasma hyopneumoniae is the causative agent of mycoplasmal pneumonia of 
swine (MPS), 1 also known as enzootic pneumonia (EP)2 or swine enzootic pneumonia 
(SEP). 3 M hyopneumoniae is present in all areas of the world where swine are raised and is 
considered to be one of the most economically important diseases of swine. 1' 2 Although 
some studies have shown no economic loss due to M hyopneumoniae,3 other studies have 
estimated the average loss to be $1.50-2.50 per pig marketed.3 
Organism 
Mycoplasmas are members of the class Mollicutes, the smallest prokaryotic 
organisms capable of self-replication.4 They lack a cell wall, but are enclosed by a complex 
membrane comprised of proteins, glycoproteins, glycolipids and phospholipids.4 
Three species ofmycoplasmas are known to cause disease in swine: M 
hyopneumoniae, which causes a chronic bronchopneumonia in pigs six weeks or older; M 
hyorhinis, which causes arthritis and polyserositis in pigs three to ten weeks old; and M 
hyosynoviae, which causes arthritis in pigs 10-24 weeks of age. 3 Although not reported in 
field cases, M hyopneumoniae may induce arthritis when inoculated intravenously.3 
A fourth mycoplasma, M flocculare is a common commensal organism and while it is not 
considered pathogenic, it may be problematic due to cross reactivity in serologic assays. 1• 5• 6 
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M. hyopneumoniae was identified as the causative organism of MPS by Mare and 
Switzer7 and Goodwin et al.8 at approximately the same time in the mid 1960's. Goodwin et 
al. named the organism they isolated M. suipneumoniae while Mare and Switzer called their 
isolate M. hyopneumoniae. It was later confirmed that both research groups had isolated the 
same organism. Subsequently, M hyopneumoniae was determined to be the correct name. 1 
Goodwin9 evaluated the ability of the organism to survive in the environment while 
investigating outbreaks in specific pathogen free (SPF) farms that possibly became infected 
by airborne transmission. He characterized the survivability of M. hyopneumoniae in various 
media and at different temperatures. He was able to recover organism by culture in sealed 
bottles of media at 113 days when stored at 0-3 ° C, but was only able to recover the 
organism from lung homogenate placed on cloth for 76 hours. Isolation of the organism 
from rainwater and tap water was variable and dependant on the original concentration of 
organism. The organism could not be isolated from air samples, human breath or human hair. 
Goodwin's results are summarized in the following table (Table 2.1). 
Table 2.1: Survivability of M. hyopneumoniae in varous media (from Goodwin9) 
Media 
Sealed bottles of mycoplasma media 
Sealed bottles of improved mycoplasma media 
Open bottles of media 
Lung homogenate 
Tap water 
Rain water 
Air, human breath, human hair 
Survival Time (based on reisolation of the 
organism) 
28 days when stored at 15-23 °C 
89 days when stored at 0-3 °C 
32 days when stored at 15-23 °C 
113 days when stored at 0-3 °C 
97 hours using mycoplasma media 
11 days using improved mycoplasma media 
96 hours on filter paper 
24-76 hours on cloth 
31 days ( concentration dependant) 
17 days ( concentration dependant) 
Not isolated 
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Antigenic determinants of M. hyopneumoniae arise from cytoplasmic membrane and 
cytosolic proteins. 10 Antibodies to these antigens have been shown to prevent organism 
adherence to the ciliated respiratory epithelium11 or block metabolic activities of the 
· · · 12 orgamsm m vitro. 
Early research found that the 38, 46, 70 and 96 kDa antigenic components of M. 
hyopneumoniae were specific for the organism. These different antigenic components have 
been used in evaluating both the antibody response to the organism and in the development 
of ELISAs to detect serum antibodies. The 46 kDa antigen elicited an early antibody 
response and these antibodies were the most commonly detected. 13 Young et al. 14 reported 
that agglutination of turkey red blood cells by M. hyopneumoniae was inhibited by 
monoclonal antibodies against a 64-65 kDa antigen. Feld et al. 15 used a monoclonal antibody 
to a 74 kDa antigen of M. hyopneumoniae in the development of a blocking ELISA. 
LePortier et al.6 developed a monoclonal blocking ELISA using a monoclonal antibody to a 
40 kDa antigen of M hyopneumoniae while Djordjevic et al. 16 used purified 43 kDa antigen 
in the development of an ELISA. 
Disease 
M hyopneumoniae causes pneumonia in swine with high morbidity and low 
mortality. 1 The disease is usually manifested as a nonproductive, sporadic, chronic cough.1 
Other clinical signs include loss of body condition, growth retardation and an "unthrifty" 
look or "lack of bloom." Average daily gain (ADG) and feed conversion (FC) can also be 
adversely affected. If present, a febrile response is usually due to the presence of secondary 
respiratory pathogens.3 
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The incubation period of the disease is considered to be ten days to three weeks, 
although outbreaks have been reported to occur after longer periods of time. 3 In an 
experimental infection, Bereiter et al. 17 found coughing began at thirteen days post 
inoculation. This is consistent with the findings of Sorenson et al. 18 who found the mean 
onset of coughing to be thirteen days post inoculation, and maximal coughing scores occured 
at twenty-seven days post inoculation. 
Growing/finishing aged swine are most commonly affected by MPS. 1 Naturally 
occurring infections with M. hyopneumoniae are predominately mixed infections with 
bacteria such as Pasteurella multocida, 19' 20 Actinobacillus pleuropneumoniae (APP), 1 
Streptococcus spp. or Staphylococcus spp. Mixed infections of M hyopneumoniae and 
viruses such as porcine reproductive and respiratory syndrome virus (PRRSV)1' 21 , swine 
influenza virus (SIV)22 and porcine circovirus type 2 (PCV2)23 are also common. 
Pathology 
M hyopneumoniae closely adheres to the cilia of respiratory epithelial cells resulting 
in damage to the epithelial cells and the mucocilliary apparatus. Adherence is mediated by a 
combination of hydrophobic forces and ligand type interactions.3 
Lesions induced by M hyopneumoniae are classically located in the cranioventral 
portion of the lung and range in color from purple to tan or gray. These lesions are 
suggestive of, but not specific for, M hyopneumoniae pneumonia.3 A catarrhal exudate in 
bronchi and bronchioles is often observed. Swollen and edematous bronchial lymph nodes 
may be observed as well. Although clinical disease lasts for approximately six weeks, lung 
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lesions may be present for up to three months after infection and lesions due to secondary 
pathogens are common.3 
Diagnosis 
Culture of the organism is considered to be the gold standard for diagnosis although it 
is rarely utilized as a diagnostic measure in field cases24 primarily due to the fastidious nature 
of the organism and frequent overgrowth by other contaminating mycoplasmas or bacteria. 1 
Macroscopic and/or microscopic examination of lung tissue for lesions characteristic of 
infection by M hyopneumoniae are non-specific, and other organisms may confound the 
diagnosis. 24 Both direct fluorescent antibody (FA) and immunohistochemistry (IHC) assays 
can be used to detect M hyopneumoniae infection in lung tissue; however both assays rely on 
the presence of the organism in the airway and low levels of infection or mishandling of 
tissue samples resulting in degradation of the airway epithelium may reduce test sensitivity.24 
In contrast, nested polymerase chain reaction (PCR) assays on bronchioalveolar lavage fluid 
are very sensitive tests as only a few organisms are required to be present for detection.24 
Serological tests used for the diagnosis of M hyopneumoniae infection include complement 
fixation (CF) and enzyme linked immunosorbant assays (ELISAs), which will be discussed 
in detail later. 1' 2 
Epidemiology 
The major source of transmission is believed to be direct contact with the respiratory 
tract secretions of carrier animals. 1' 2 Transmission can occur from gilts and young sows to 
their offspring, and older pigs are known to transmit M. hyopneumoniae to younger pigs in 
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continuous flow systems.2 Reports also imply that aerosol or indirect transmission may be an 
important route of infection. 9• 25-27 Morris et al. 28 found that pen mates or pigs in adjacent 
pens were seven times more likely to develop antibodies to M hyopneumoniae following 
natural infections. 
Leon et al. 25 sampled colostrum from newly farrowed sows and sequentially tested 
their offspring by ELISA at 10, 27, 70, 94, 125 and 147 days of age. They reported that the 
critical time period for transmission of M. hyopneumoniae appeared to be at the beginning of 
the finishing period (approximately 70 days of age). They theorized that declining 
concentrations of maternally derived antibodies, combined with stresses such as the moving 
and mixing of animals results in the increased incidence of infection at this particular age. 25 
Leon et al. also reported coughing began at approximately the same time as 
seroconversion and suggested that coughing could be used as an indicator of the M 
hyopneumoniae infection status of pigs. 25 However, other reports contradict these findings. 
Bruggmann et al. 29 were able to detect antibodies to M hyopneumoniae several weeks prior 
to the onset of clinical signs and Bereiter et al. 17 were able to detect antibodies by ELISA 
three weeks post infection, but did not report coughing until 13 weeks post infection. 
In a study by Andreason et al.,30 eight farrow-to-finish herds seropositive for M 
hyopneumoniae and APP were used to compare seroconversion to ADG. Pigs were tested 
for serum antibodies to M hyopneumoniae at 4, 8, 12, 16 and 20 weeks. The authors found 
no relationship between seroconversion time ( early or late) and ADG, which concurs with the 
findings of Morris et al. 28 but conflicts with the results of Wallgren et al. 31 Wallgren et al. 31 
propose that either subclinical M. hyopneumoniae infections have no effect on ADG or the 
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increased growth rate after recovery from M. hyopneumoniae infection eclipses the decreased 
ADG in the clinical phase of infection. 
Prevalence 
Young et al. 32 conducted a study to determine the prevalence of M hyopneumoniae 
in Iowa. Serum samples submitted to the Iowa State University Veterinary Diagnostic 
Laboratory (ISU-VDL) for pseudorabies antibody testing in the first quarter of 1980 were 
used in the study. The samples were obtained from breeding stock tested for sale or were 
from pseudorabies virus free herds. The samples were tested for antibodies to M 
hyopneumoniae using a CF assay. A total of 7,321 samples from 597 herds were tested. Of 
the samples tested, 1600 (21.9%) were positive, and 60% of herds tested had at least one 
positive animal. 
The NAHMS 2000 swine survey categorized herds as small ( <250 sows and gilts or 
<2000 nursery and finishing pigs) medium (250-499 sows and gilts or 2000-9999 nursery 
and finishing pigs) or large (>500 sows and gilts or >10,000 nursery and finishing pigs). The 
survey found M. hyopneumoniae in U.S. to be the third most commonly reported disease 
problem on U.S. swine farms with breeding females. 33 Overall, 14.2% of farms with 
breeding females reported mycoplasma pneumonia as a problem. Larger farms were more 
likely to report mycoplasma pneumonia as a problem (33.9%) compared to medium (22.5%) 
or small (11.0%) sized farms. 
Pneumonia caused by M hyopneumoniae was the fourth most commonly reported 
disease problem in nursery-aged pigs in the NAHMS 2000 survey.33 Overall, 19.6% of sites 
with nursery pigs reported M hyopneumoniae as a problem. Again, larger farms were more 
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likely to identify M hyopneumoniae as a problem (52.7%) than were medium (41.5%) or 
small (14.6%) farms. In grower and finisher pigs, mycoplasma pneumonia was reported as a 
problem in 29% of all herds, making it the second most reported problem. 33 Again, large 
farms had more problems with M hyopneumoniae pneumonia (68.0%) than did medium 
(55 .7%) or small (22.8%) farms. 
M. hyopneumoniae and viral pathogens 
The ability of M hyopneumoniae to potentiate viral infections varies with the 
pathogen.22 M hyopneumoniae has been shown to increase the severity of lung lesions and 
the clinical disease when co-infected with PRRSV21 although PRRSV did not appear to 
exacerbate M hyopneumoniae infections. 34 Antibody levels (as measured by ELISA) did not 
appear to be affected by co-infection with the PRRSV.34 Co-infection of pigs with PCV2 
appears to have a similar impact on M. hyopneumoniae infection by significantly increasing 
the severity and duration of pneumonia.35 
Thacker et al.22 co-infected pigs with M. hyopneumoniae followed by swine influenza 
virus (SIV) 21 days later. In this study, they found that dual pathogen infected pigs had 
significantly more clinical disease, as measured by coughing, than those infected with M 
hyopneumoniae or SIV alone. The authors concluded that while pigs infected with both M 
hyopneumoniae and SIV exhibited more severe clinical disease, the potentiation observed in 
pigs dually infected with M hyopneumoniae and PRRSV or PCV2 was not apparent. 
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Indirect ELISA 
The first report of the use of an ELISA to detect antibodies to M. hyopneumoniae was 
in 1977 by Bruggmann et al. 29 They found that antibodies to M hyopneumoniae were 
detectable in the serum of experimentally infected pigs several weeks prior to the onset of 
clinical signs, and that serum from those pigs remained ELISA positive for at least 50 weeks 
post inoculation. They concluded that the ELISA was an improvement over radio-
immunoassays as the sensitivities were similar and the ELISA required less specialized 
equipment. 
Armstrong et al. used a SDS extracted whole cell M hyopneumoniae ELISA on field 
samples in 1978.36 At slaughter, they found 33 of 33 pigs without lung lesions suggestive of 
M. hyopneumoniae negative for antibodies to M hyopneumoniae, while 32 out of the 33 
were seronegative by the CF test. In pigs with lung lesions consistent with M 
hyopneumoniae, 13 of 18 were seropositive by ELISA, while 18 of 18 were positive by CF. 
They found that antibodies to M flocculare and M hyosynoviae in the serum of 
experimentally infected pigs appeared to cross react with M. hyopneumoniae antibodies in 
the ELISA. These results disagreed with the findings of Bruggman et al. 29 and they 
concluded that an ELISA for M. hyopneumoniae was less specific than desired and suggested 
that the specificity of the test needed to be improved before the ELISA could be widely 
applied for field diagnostics. 
Armstrong et al.37 continued to investigate the use of M hyopneumoniae ELISAs by 
assessing contact transmission using caesarian derived colostrum deprived (CDCD) pigs 
intranasally inoculated with M. hyopneumoniae and mixed with uninoculated CDCD pigs. 
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Two of three inoculated pigs had antibodies detectable by ELISA and indirect 
hemagglutination assay (IHA) at 28 days post inoculation and all three pigs had antibodies 
detectable by indirect immunofluorescent assay (IIF) and CF at that time. By day 42 post 
inoculation, all three pigs were seropositive by ELISA, IHA, IIF and CF. At necropsy, M 
hyopneumoniae was isolated from the lungs of all three inoculated pigs. Two of the five 
contact exposed pigs seroconverted to M. hyopneumoniae by 28 days, and all five were 
positive by 52 days post contact. At nine weeks post contact, M. hyopneumoniae was 
isolated from all four pigs that were necropsied. The fifth pig was not necropsied so that the 
serological response could be followed for a longer period of time. This pig continued to be 
seropositive at 174 days post contact. 
In another study, Armstrong et al.37 further investigated the properties of a M 
hyopneumoniae ELISA. They found that the ELISA cross reacted with M hyorhinis, M. 
floculare and M hyosynoviae antibodies at 60 and 100 days post inoculation, whereas the 
IHA, the IIF and the CF assay showed less cross reactivity. 
Based on the data of these two experiments, Armstrong et al. concluded that the 
ELISA had minor cross reactions with M hyorhinis and major cross reactions with M 
flocculare. They found the ELISA to be the least specific of the four tests in detection of 
early infection with M hyopneumoniae. Further evidence of cross reactivity by the porcine 
mycoplasmas were demonstrated by Sands et al. in 1982.38 They concluded that the cross 
reactivity among porcine mycoplasmas accounted for the reduced specificity of the ELISA. 
Freeman et al. 39 found the greatest cross-reaction to be between M hyopneumoniae and M 
flocculare. The cross-reaction was less evident between M. hyopneumoniae and M. 
hyosynoviae. In another study,4° Freeman et al. determined that cross-reaction between M. 
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hyopneumoniae and M jlocculare was not observed with their ELISA. In a study of pigs 
experimentally infected with M. flocculare, Armstrong et al.41 found all sera from M 
jlocculare infected pigs to be negative on the M. hyopneumoniae ELISA, and concluded that 
M flocculare infected swine did not develop a sufficient antibody response to interfere with 
the M hyopneumoniae ELISA. 
In response to the need for a more specific assay for M hyopneumoniae, a modified 
indirect ELISA for detection of serum antibodies to M hyopneumoniae was developed by 
Nicolet et al. 5 They found that treating the antigen with the neutral detergent Tween 20 was 
superior to the anionic detergent sodium dodecyl sulfate (SDS) to solublize the antigens and 
reduce cross reactivity. They were able to detect antibodies to M hyopneumoniae using this 
ELISA at two weeks after experimental challenge in one of five pigs and at three weeks post 
challenge in three of five pigs. All five pigs were positive by ELISA by four weeks and M 
hyopneumoniae antibodies were found to persist for at least ten weeks. They concluded that 
the detergent treatment reduced, but did not eliminate non-specific cross-reactions. The 
authors suggested that some of the non-specific reaction seen was due to nucleic acid or 
ribosomal interference. 
Schuller and Swododa42 compared the CF and ELISA to histopathological 
examination oflesions consistent with M hyopneumoniae infection. They found 67.3% of 
their samples had lesions consistent with M hyopneumoniae infection, while 38.6% were 
positive by ELISA and 26.7% were positive by CF. They concluded that serology for M 
hyopneumoniae was useful on a herd basis, but not on an individual animal basis. Piffer et 
al.43 were able to detect antibodies by ELISA 2 weeks post inoculation. They found that the 
ELISA was more sensitive than CF for detection of M hyopneumoniae antibodies three to 
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five weeks post inoculation, and that the tests were similar for detection at six to seven weeks 
post inoculation. Armstrong et al.44 first detected antibodies to M. hyopneumoniae by ELISA 
five weeks after contact exposure to infected swine. The ELISA antibody titer persisted for 
at least 52 weeks in this study. 
Zimmermann et al. 45 evaluated a commercial M. hyopneumoniae ELISA using blood 
and colostrum samples obtained from M hyopneumoniae-free and M hyopneumoniae-
infected herds. They found all 575 blood and colostrum samples were negative from M 
hyopneumoniae-free herds and 140 of 634 (22%) serum samples and 202 of 472 (43%) 
colostrum samples obtained from M. hyopneumoniae-infected herds were positive. 
Zimmerman et al. 46 concluded that the M. hyopneumoniae ELISA was useful for detection of 
acute outbreaks of M hyopneumoniae, but was of little value in endemically infected herds 
due to the difficulty in interpreting test results. 
Bereiter et al. 17 modified the Tween 20 ELISA described by Nicolet. 47 The assay was 
then consistently able to detect antibodies to M hyopneumoniae by three weeks post 
inoculation and antibodies were detectable for at least one year. They reported slight cross 
reactivity between the M hyopneumoniae antigen and high levels of antibodies to M. 
jlocculare. 
Strasser et al.48 were unable to detect cross-reacting antibodies to M hyopneumoniae 
in pigs experimentally infected with M. jlocculare using an ELISA. Conversely, there were 
at least three antibodies to M. jlocculare that recognized M hyopneumoniae proteins in pigs 
experimentally infected with M hyopneumoniae.48 In pigs experimentally infected with M 
hyopneumoniae, the initial antibody response was observed at 4-5 weeks post inoculation 
15 
while animals infected at 2 weeks of age had a greater antibody response and greater 
magnitude of clinical signs than pigs inoculated at 8 weeks of age. 
Djordjevic et al. 16 compared the commercial ELISA evaluated by Sheldrake and 
Romalis49 to an ELISA using a 43 kDa purified protein antigen from M hyopneumoniae 
cytoplasmic membrane. They found the ELISA using the 43 kDa antigen had significantly 
higher ELISA ratios than the commercial ELISA evaluated by Sheldrake and Romalis,49 
which was based on column purified, sonicated proteins of M hyopneumoniae. 
Sorenson et al. 18 found the ELISA to be 100% specific, but the sensitivity of the assay 
decreased as length from inoculation increased, presumably as the infection was cleared. 
However, most of the assays used in the studies described above utilized different antigen 
sources, derived either through the use of detergents or other mechanisms to disrupt the cell 
membranes. In addition, some assays used primarily cell membranes, while other assays 
consisted of whole cells. These differences may also contribute to the variation in the ability 
of the various assays to detect antibodies as well as variation in the ability of individual pigs 
to produce antibodies to the organism. Currently, two indirect ELISAs are available 
commercially in the U.S. 
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Blocking ELISA 
The use of monoclonal antibodies in blocking ELISAs allows the sensitivity of the 
assay to be determined by the detector antibody, rather than the antigen. Thus, using a 
monoclonal antibody specific to an epitope unique to the organism greatly reduces or can 
eliminate problems with cross reactivity. 
Feld et al. 15 developed a blocking ELISA to M. hyopneumoniae using purified 
monoclonal antibody directed against a 74 kDa outer membrane protein. They were able to 
detect an antibody response at two weeks post inoculation and concluded that seroconversion 
took place between weeks one and two post inoculation. They also found that antibody titers 
peaked eight to nine weeks post exposure. Contact exposed pigs developed an antibody 
response at four to five weeks post exposure. 
Another blocking ELISA was developed by Le Portier et al. 6 In this ELISA, the 
monoclonal antibodies were directed against a 40 kDa outer membrane protein. They found 
that antibodies to the 40 kDa membrane protein were the first antibodies detectable by 
immunoblot at two weeks post inoculation, and persisted for at least 20 weeks. All 
experimentally infected animals were found to be seropositive by three to four weeks post 
inoculation using this ELISA. They also found no cross-reaction with M hyorhinis or M. 
flocculare antibodies. Additionally, they compared the blocking ELISA with an indirect 
ELISA5 on field serum samples and found the relative sensitivity to be 93.6%, the relative 
specificity to be 99.2% and the agreement between the tests to be 97.1 %. 
The results of these studies suggest that the use of monoclonal antibodies to specific 
M hyopneumoniae antigens may increase both the specificity and speed in detecting 
18 
antibodies. Currently one ELISA based on this technology is available commercially in the 
U.S. 
Diagnostic Test Evaluation 
Test Performance Statistics 
There are basically two types of results produced by diagnostic tests. A test can yield 
a dichotomous answer (positive or negative) or a continuous variable ( e.g. OD values from 
an ELISA). Continuous tests can be made dichotomous by selecting a cutoff to determine 
positive or negative status using the methods described below. 
Sensitivity and Specificity 
A two by two contingency table, as shown in table 2.3, in which the test in question is 
compared to the true disease status of the animals, can be used for generating some basic test 
statistical analysis. The sensitivity of a test, or true positive rate (TPR), is the rate at which 
the test classifies truly positive samples as positive. The sensitivity is calculated as a/(a+c). 
The specificity of a test, or true negative rate (TNR), is the rate at which the test correctly 
classifies truly negative samples and is calculated as d/(b+d). Sensitivity and specificity are 
inversely related. Test cut-offs for positive and negative classification can be changed based 
on either the TPR or the TNR. If a cut-off is changed to make the test more sensitive (i.e. to 
detect more positives), the specificity of the test will usually decrease (i.e. there will 
potentially be more false positives). 
19 
Predictive Values 
The positive predictive value (PPV) is the probability of a positive test result coming 
from a truly diseased animal, and is calculated as a/( a+b ). The negative predictive value of a 
test is the probability of a negative test result coming from a truly negative animal and is 
calculated as d/( c+d). 
True and Apparent Prevalence 
The true prevalence of a disease is the number of disease positive animals. True 
prevalence is calculated as the number of diseased animals divided by the total number 
tested. Thus, true prevalence= (a+c)/(a+b+c+d). The apparent prevalence is the disease 
prevalence indicated by the number of test positive animals. Apparent prevalence= 
(a+b )/(a+b+c+d). 
Table 2.3: A standard 2 x 2 contingency table . 
Test 
Result 
Conditional Dependence of Tests 
Disease Status 
a+c b+d 
a+b 
c+d 
a+b+c+d 
Conditional dependence can be measured as a covariance reflecting the degree to 
which test results are more concordant than would be expected by chance for binary tests. 
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Gardner provides an outline for calculating conditional dependence ofrelated tests. 50 A 
limiting factor of conditional dependence is that only two tests can be compared. In order to 
compare more than two tests, logistic or log-linear modeling can be used. Evaluation of the 
conditional-dependence structure between tests allows for selection of tests (number and 
sequence) to obtain cost effective protocols with acceptable sensitivity and specificity.21 • 22 
Multiple Test Interpretation 
When more than one test is available to diagnose a disease, different testing schemes 
can be used depending on the objectives of the tester. Multiple tests can be interpreted either 
in series or in parallel. Parallel test interpretation means that a positive result on any test is 
positive, while serial test interpretation assumes that all tests must be positive for a sample to 
be considered positive. Parallel interpretation emphasizes sensitivity, while serial test 
interpretation places emphasis on specificity.50• 5 1 
21 
CHAPTER 3: EVALUATION OF THREE SERUM ANTIBODY 
ELISA TESTS FOR MYCOPLASMA HYOPNEUMONIAE 
A paper accepted by The Journal of Swine Health and Production 
Authors: Keith R. Erlandson, DVM BS, Richard B. Evans, PhD, Brad J. Thacker, DVM, 
PhD, MBA, Diplomate ABVP, Matthew W. Wegner, DVM and Eileen L. Thacker, DVM, 
PhD, Diplomate ACVM 
Summary 
Objective 
Compare the performance of three ELIS As in detecting M hyopneumoniae serum 
antibodies from M hyopneumoniae negative and experimentally inoculated pigs. 
Methods 
Archived serum samples from experimentally infected and known negative swine 
were tested using three Mycoplasma hyopneumoniae ELISAs. The tests evaluated included a 
Tween 20 ELISA and two commercially available ELISA tests manufactured by DAKO and 
IDEXX. Statistical analysis including, Kappa coefficients, receiver operating characteristic 
(ROC) curves and covariance of tests were used to compare the three assays. 
Results 
This study found the sensitivities of all three assays to be lower than previously 
reported in the literature. The blocking ELISA was found to be the most sensitive of the three 
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assays compared. All three assays had excellent specificity. Using tests in combination was 
found to increase the sensitivity. 
Implications 
• Mycoplasma hyopneumoniae ELISA assays may be less sensitive than 
previously reported, especially for vaccinated animals and animals less than 
21 days post infection. 
• These assays are inefficient at detecting serum antibodies in the early stages of 
infection; therefore, care should be exercised when interpreting results. 
• Using a combination of tests to increase sensitivity may be valuable for the 
diagnosis of M hyopneumoniae infection. 
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Introduction 
Mycoplasma hyopneumoniae is an economically important pathogen affecting swine 
production worldwide. 1 Alone, M hyopneumoniae causes a mild bronchopneumonia, but 
can exacerbate pneumonia caused by viral pathogens such as porcine respiratory and 
reproductive syndrome virus (PRRSV).21 Infection with M hyopneumoniae enables invasion 
by secondary bacterial pathogens such as Pasteurella multocida.52 For these reasons, there is 
much interest in surveillance and testing for this pathogen. 
There are currently several enzyme linked immunosorbant assays (ELISA) 
commercially available for the detection of M. hyopneumoniae. These ELISAs are based on 
detection of the antibodies to M hyopneumoniae in swine serum. Unfortunately, because M 
hyopneumoniae attaches to the ciliated respiratory epithelium and is not invasive, the serum 
antibody response to the bacteria can be variable. This variable antibody response leads to 
problems with assay interpretation, especially due to false negative results. 
The relationship of test results to the presence or absence of M. hyopneumoniae in 
swine has been controversial. Although ELISAs for detection of M. hyopneumoniae 
antibodies have been extensively used, there is little information in the scientific literature as 
to the epidemiological properties of these tests. 5' 17' 53 ' 54 The objective of this study was to 
compare the performance of three ELISAs in detecting antibodies to M hyopneumoniae in 
serum from M. hyopneumoniae negative and experimentally inoculated and vaccinate, 
experimentally inoculated pigs. 
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Materials and Methods 
Archived serum samples from 51 experimentally infected (ten unvaccinated pigs :S 21 
days post infection and 41 vaccinated pigs> 21 days post infection) and 17 unvaccinated 
known negative serum samples were tested using three ELISAs. The experimentally infected 
pigs had been inoculated intratracheally with M hyopneumoniae strain 232 (a derivative of 
strain 11) during previous studies. 55' 56 The three antibody assays evaluated included a 
Tween 20 ELISA 17, and two commercially available ELISA tests, HerdChek® M hyo 
produced by IDEXX Laboratories (IDEXX Laboratories, Westbrook, ME) and the DAKO 
Mycoplasma hyopneumoniae ELISA (DAKO Corporation, Carpenteria, CA). The Tween 20 
and HerdChek® tests are indirect ELISA tests, whereas the DAKO M hyopneumoniae test is 
a blocking ELISA. The DAKO test available in the United States differs from the test 
available in other countries. A different substrate is used, and the test stop solution is not 
included and must be prepared by the laboratory running the test. This lack of standardized 
reagents with the DAKO test may create problems with regard to the accuracy of the test 
within and among laboratories. 
Classification of the M. hyopneumoniae antibody level of a sample for the Tween 20 
ELISA is typically based on the optical density (OD) value of the sample. 17 All samples 
were run in duplicate and the average OD of the two wells was used to determine M 
hyopneumoniae serostatus. The positive control is "normalized" to an OD of 0.4, and a 
formula is used to adjust the sample OD based on the positive sample adjustment. A positive 
result with the Tween 20 was defined as an OD of 2:0.24, ODs of 0.20-0.24 were classified as 
suspect, and ODs of <0.20 were classified as negative. 
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It is also possible to use a sample to positive (S/P) ratio for classification of samples 
with the Tween 20 ELISA. Accordingly, an S/P of2:0.5 was considered positive, S/P ratios 
0.4 to 0.5 were classified as suspect and SIP ratios of <0.4 were considered negative. 
The HerdChek® test bases the sample classification on the S/P ratio. The SIP ratio is 
defined as: 
S~=--=Sa=m=p~le~O=D_-~N~e=g=at=iv~e~C=o=n=tr=o~IO=D=----
Positive Control OD - Negative Control OD 
Positive SIP ratios were > 0.4, SIP ratios of 0.3 to 0.4 were classified as suspect and 
S/P ratios< 0.3 were classified as negative. All samples were run in duplicate, and the 
average of the two wells was used to calculate the SIP ratio. 
The DAKO ELISA test result is based on the comparison of the sample OD to the OD 
of the buffer control, yielding a percent inhibition value. A sample was classified as positive 
if the percent inhibition of the sample was :S50% of the of the buffer control. Samples with an 
OD >50% of the buffer control were classified as negative. The DAKO test does not classify 
samples as suspect, but the manufacturer's instructions include the caveat that animals with 
serum samples with ODs between 50% and 65% of the buffer control should be retested in 
two weeks. All samples were run in duplicate, and the average of the two wells was used to 
calculate the percentage of the buffer control. 
Analysis of Test Properties 
Kappa 
The kappa coefficient is a method of determining agreement between observers (tests 
in this case) beyond that of chance. It should be noted that the kappa coefficient measures 
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the strength of agreement between tests; it does not provide a comparison to a gold standard 
or known disease status. Therefore, two assays may have a high level of agreement (high 
kappa score), but be equally poor at detection of disease or correctly classifying negative 
animals. The three assays were evaluated with the kappa coefficient using published 
benchmarks57, where a kappa value= 0 is classified as poor agreement; kappa values from 
0.01 - 0.20 constitute is slight agreement; kappa values from 0.21 - 0.40 constitute fair 
agreement; kappa values from 0.41 - 0.60 constitute moderate agreement; kappa values from 
0.61 - 0.80 constitute substantial agreement; and kappa values 2: 0.81 constitute perfect 
agreement. 
ROC Curves 
The receiver operating characteristic (ROC) curve is a method of test evaluation and 
cutoff selection. The sensitivity of a test (true positive rate) is plotted on the X axis while 1-
specificity (false positive rate) is plotted on the Y axis at multiple possible cutoff points. A 
curve is then drawn connecting these points and the area under the curve (AUC) is 
calculated. The ROC curve can be used to select a cutoff point that represents the objectives 
of the tester. If a high specificity is desired, a cutoff can be selected to maximize specificity, 
but some sensitivity may be sacrificed. Likewise, a cutoff can be selected to maximize 
sensitivity, usually at the expense of some specificity, or a cutoff can be selected for maxim 
sensitivity and specificity. The area under the ROC curve for each test can be compared to 
determine the relative performance of the tests. 
27 
ROC curve analysis was performed using the freeware program ROCKIT. ROCKIT 
uses the Alf-Dorfman maximum likelihood method for estimation of AUC,58 and the 
procedure described by Hanley and McNeil59 for comparison of AUCs. 
Covariance of Tests 
When tests evaluate disease status based on the same or similar biologic processes, 
such as serum antibody levels in the case of M. hyopneumoniae ELISAs, it is logical to 
assume that they are correlated to some degree. This correlation is known as the test 
dependence. so A test of covariance can be used to determine the degree to which the tests are 
dependant. In this study, covariance of the tests was estimated using the procedure described 
by Gardner.50 The covariance value is directly related to the magnitude of the dependence, 
so covariance is expressed as the percentage of the maximum possible value of the 
covariance. so 
Combination Tests 
The performance of test combinations was evaluated using the method described by 
Gardner.50 When using tests in parallel ("OR" testing scheme), one positive test result 
classifies the animal as positive. When testing in series ("AND" testing scheme), all tests 
must be positive for the animal to be classified as positive.50 
The dependence of the tests is important when using multiple tests. If tests are highly 
dependant ( e.g. two ELISAs testing for serum antibody), there may be little information to be 
gained by multiple tests. However, if two tests have a low dependence ( e.g. ELISA for 
serum antibody and PCR for detection of the organism), more information can be gained by 
using multiple tests. 
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Statistical Analysis 
For statistical analysis in this study, suspect samples were considered negative 
because we considered suspect samples to be a subset of negative samples, and the suspect 
classification is useful for identification of animals for further testing. Statistics were 
computed using SAS 8.02 (SAS Institute, Cary, NC), with the exception ofROC curves, 
which were evaluated using the freeware program ROCKIT (ROCKIT, University of 
Chicago, Chicago, Illinois). 
Results 
Test Properties 
Table 3. 1 provides a summary of test results for each category from the three 
ELISAs, and Tables 3.2, 3.3 and 3.4 present the 2 x 2 contingency tables of the tests for the 
categories. When results for the all experimentally infected pigs, including both positive and 
negative sera combined, the Tween 20 ELISA had a sensitivity of 0.35, the HerdChek® 
ELISA had a sensitivity of0.37 and the DAKO ELISA had a sensitivity of 0.49. For the 
unvaccinated early positives, the Tween 20 ELISA had a sensitivity of 0.00, the HerdChek® 
ELISA had a sensitivity of0.30 and the DAKO ELISA had a sensitivity of 0.60. When used 
on vaccinated, late positives, Tween 20 ELISA had a sensitivity of 0.44, the HerdChek® 
ELISA had a sensitivity of 0.39 and the DAKO ELISA had a sensitivity of 0.46. All three of 
the assays correctly identified known negative samples, resulting in a specificity of 1.0 for all 
three tests. Table 3.5 provides a summary of the properties of the three assays. 
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Kappa 
Table 3.6 presents the kappa coefficients for the tests. Comparison test results for all 
sera from experimentally challenged pigs (unvaccinated and vaccinated) resulted in 
substantial agreement between the Tween 20 and the HerdChek® tests with kappa=0.70 
(P<0.001), moderate agreement between the HerdChek® and DAKO tests, kappa=0.53 
(P<0.001), and fair agreement between the Tween 20 and DAKO tests, kappa=0.25 
(P=0.021). 
Agreement between the HerdChek® and DAKO tests for early positive samples was 
moderate with kappa=0.44. For early positive samples, agreement between the Tween 20 
and the HerdChek® and the Tween 20 and the DAKO was no better than that expected by 
chance. Agreement between tests was largest when comparing the vaccinated late positive 
samples. There was substantial agreement between the Tween 20 and the HerdChek® tests 
with kappa=0.80 (P<0.001), moderate agreement between the HerdChek® and DAKO tests, 
kappa=0.55 (P<0.001), and fair agreement between the Tween 20 and DAKO tests, 
kappa=0.36 (P=0.010). 
ROC Curve Analysis 
Table 3.7 provides a summary of the Wilcoxon estimate of the AUC, as calculated by 
ROCK.IT, for the three tests on all serum samples from experimentally infected pigs. Table 
3.8 summarizes the maximum likelihood estimation of the AUC. The maximum likelihood 
estimates differ due to the numerical accuracy of the algorithm ROCK.IT uses to compute 
them. 
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The AUC for the Tween 20 test was significantly smaller than that of the DAKO 
(p=0.0078) and the HerdChek® (p=0.0094). This indicates that the Tween 20 ELISA has the 
poorest potential performance of the three tests. The AUC of the HerdChek® was not 
significantly different than the AUC of the DAKO, indicating that the optimum performance 
for these two tests is equal. 
Covariance of Tests and Interpretation of Multiple Tests 
Covariance value and percentage of maximum covariance are shown in Table 3.9. 
In this study, all known negative samples were correctly classified as negative by all three 
tests, resulting in a specificity of 1. For this reason, the covariances of the test specificities 
were not calculated, since the specificities of tests with perfect specificities are independent 
by definition.50 Table 3.10 provides a summary of the properties of the tests when used in 
combination. 
Discussion 
The performance of M hyopneumoniae ELISA tests is not well documented in the 
current literature, especially concerning the performance on vaccinated animals and animals 
in the early stages of infection. Our objective with this study was to determine the relative 
ability of the three ELISA tests to detect infection by M hyopneumoniae in swine at or near 
the point of maximal pneumonia (approximately 28 days post inoculation). Using of samples 
from experimentally infected animals allowed for the evaluation of the tests ability to detect 
infection during the period of maximal pneumonia. 
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All three of the assays evaluated had excellent specificities, correctly identifying 
negative samples. The sensitivity of the assays determined in this study was found to be 
lower than other published reports.4-7 These low test sensitivity results may be based on the 
vaccination status of some animals, and the early infection of others. It should be noted that 
the low sensitivities found are not necessarily indicative of poor quality of the tests, but 
rather the variable and often delayed immune response generated by M hyopneumoniae. 
Using McNemar's test, there were no significant statistical differences detected 
between the assays, with the exception of the Tween 20 and DAKO tests, which were found 
to be statistically different (p<0.05) when used on the unvaccinated early challenged group. 
Although these differences were not statistically significant, of the three tests 
evaluated, the DAKO test had the highest sensitivity at 0.49 based on the combined positive 
group, with 0.46 for the vaccinated late positive group and 0.60 for the unvaccinated early 
positive group. Tween 20 and the HerdChek® tests were less sensitive than the DAKO in all 
categories. 
The DAKO assay was statistically superior at picking up early infections (six out of 
ten) compared to the Tween 20 ELISA (zero out often). The DAKO test picked up more 
early infections than the HerdChek® (three out of ten), although the result was not 
statistically significant by McNemar's test. Thus, we believe the DAKO assay to be the best 
choice for early detection of infection. 
Calculated kappa statistics showed the largest agreement between the Tween 20 
ELISA and the HerdChek® ELISA, and the lowest agreement between the Tween 20 ELISA 
and the DAKO ELISA. 
32 
ROC analysis showed that the HerdChek® and DAKO ELISAs did not statistically 
differ from each other and were both superior to the Tween 20 ELISA. It should be noted 
that positive and negative classifications in this paper were based on the standard cutoffs of 
the ELISAs. It may be useful to modify cut-off points for classification of positive samples 
to improve the sensitivity of the assays tested. 
The Tween 20 and the HerdChek® test had the largest agreement as measured by 
Kappa, as well as the largest sensitivity covariance. This is logical as two of the tests were 
the same type of indirect ELISAs, while the DAKO is a blocking ELISA. 
The Tween 20 and DAKO had the smallest covariance (i.e. they were less 
dependant), and had the highest sensitivity when used in a parallel interpretation scheme. 
Thus, it is suggested if multiple ELISAs are to be used, the DAKO monoclonal blocking 
ELISA should be used in combination with the either the HerdChek® or the Tween 20 
indirect ELISAs to maximize sensitivity. 
This study was limited due to a small sample size, especially for evaluation of test 
properties with true negative animals. Additionally, most pigs were necropsied at or near 28 
days post infection; so there was no opportunity to follow the serological status over time. 
Further studies with more animals may be able to detect statistically significant differences in 
the three assays. Studies of longer duration would be beneficial to further quantify the 
serological reaction to M. hyopneumoniae and test properties for detection of infection by 
serum testing. 
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Tables 
Table 3.1: Summary of Test Results 
Cate or N Tween 20 HerdChek DAKO 
17 
10 
Late Positive 41 
All Positives 51 
Table 3.2: 2 x 2 Contingency Tables Comparing the ELISA Results of All Infected Animals. 
HerdChek 
Tween20 I + I ~ I 2;J 
19 32 
HerdChek 
I 
+ 
i 
-
I 
DAKO 
I 
+ 16 9 
3 23 
19 32 
DAKO 
+ -
Tween20 I + 12 6 I - 13 20 
25 26 
18 
33 
51 
25 
26 
51 
18 
33 
51 
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Table 3.3: 2 x 2 Contingency Tables Comparing the ELISA Results of Early Infected, Non-vaccinated 
Animals. 
HerdChek 
Tween20 I + I ~ I ~ I 
3 7 
HerdChek 
I 
+ 
I 
-
i 
DAKO 
I 
+ 3 3 
0 4 
3 7 
DAKO 
I 
+ 
: 
-
I 
Tween20 I + 0 0 6 4 
6 4 
0 
10 
10 
6 
4 
10 
0 
10 
10 
Table 3.4: 2 x 2 Contingency Tables Comparing the ELISA Results of Late Infected, Vaccinated Animals. 
HerdChek 
Tween20 I + I 1~5 I 2~ I 
16 25 
HerdChek 
I 
+ 
I 
-
I 
DAKO 
I 
+ 13 6 
3 19 
16 25 
DAKO 
I 
+ 
I 
-
I 
Tween20 I + 12 6 7 16 
19 22 
18 
23 
41 
19 
22 
41 
18 
23 
41 
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Table 3.5: Summary of Test Properties. 
False Positive False Negative Rate 
Test Sensitivity (%) Specificity (%) PPV NPV Rate(%) (%) 
Tween20 35.3 100 1 0.34 0 64.7 
HerdChek 37.3 100 1 0.35 0 62.8 
DAKO 49.0 100 1 0.40 0 51.0 
Table 3.6: Summary of kappa for test agreement 
All Positives Early Positives Late Positives 
Test (N=Sl) (N=lO) (N=41) 
Kappa p 
Tween 20 x HerdChek 0.703 <0.0001 
Tween 20 x DAKO 0.251 0.0313 
HerdChek x DAKO 0.527 <0.0001 
Table 3.7: Comparison of Area Under the Curve for three tests. 
Tween 20 
HerdChek 
DAKO 
AUC (Wilcoxon) 
0.8622 
0.9158 
0.9815 
Kappa p Kappa p 
- - 0.7995 <0.0001 
- - 0.3601 0.0105 
0.4444 0.0455 0.5538 0.0002 
Table 3.8: The area under the curve, A(z) (an estimation of the area under the fitted smooth curve) and the 95% 
asymmetric confidence interval for the three tests. 
I Tween 20 HerdChek DAKO 
Tween 20 - 0.87 (0. 75,0.95) 0.87 (0.74, 0.94) 
HerdChek 0.92 (0.83, 0.97) - 0.92 (0.83, 0.97) 
DAKO 0.98 (0.93, 1.00) 0.99 (0.94, 1.00) -
Table 3.9: Comparison of covariances of three tests on all positive animals. 
Covariance Estimate Percent of Maximum Covariance 
Tween 20 x HerdChek 0.16 73.5 
Tween 20 x DAKO 0.06 34.6 
HerdChek x DAKO 0.13 69.0 
T bl 3 10 E . a e : strmat10n o sens1t1v1ty o t e t f f h hr h ee tests w en use m com mat10n. d' b' 
Parallel Serial 
Tween 20 HerdChek 0.43 0.29 
Tween 20 DAKO 0.61 0.23 
HerdChek DAKO 0.55 0.31 
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CHAPTER 4: COMPARISON OF TWO ELISA TESTS FOR 
DETECTION OF MYCOPLASMA HYPPNEUMONIAE USED IN THE 
NATIONAL ANIMAL HEALTH MONITORING SYSTEM SWINE 2000 
SURVEY 
A paper to be submitted to The Journal of Swine Health and Production 
Authors: Keith R. Erlandson, DVM, Richard B. Evans, PhD, Eric J. Bush, DVM, MS, Brad 
J. Thacker, DVM, PhD, MBA and Eileen L. Thacker, DVM, PhD 
Introduction 
Mycoplasma hyopneumoniae causes mycoplasmal pneumonia of swine (MPS), also 
know as enzootic pneumonia (EP) and is a contributor to the porcine respiratory disease 
complex (PRDC).1 M. hyopneumoniae is an economically important pathogen affecting 
swine production worldwide.1 It was the second most commonly cited disease problem in 
growing/finishing pigs in the National Animal Health Monitoring System (NAHMS) 2000 
swine survey. 60 
Several serological assays have been developed to detect antibodies to M 
hyopneumoniae in swine serum including complement fixation (CF) and the enzyme linked 
immunosorbant assay (ELISA). There are currently ELISAs commercially available for the 
detection of M hyopneumoniae. This study concentrated on the relative performance of two 
indirect ELISAs for the detection of M hyopneumoniae in swine serum; the Tween 20 
ELISA17 and the Herd Chek® (IDEXX Laboratories, Westbrook, ME) ELISA. 
The (NAHMS) Swine 2000 survey collected samples to be tested using the Tween 20 
and Herd Chek® (IDEXX) ELISAs. The objective of this study was to compare the 
performance of these indirect ELISAs in detecting antibodies to M. hyopneumoniae in serum 
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samples collected during the NAHMS Swine 2000 survey. A third commercially available 
blocking ELISA (DAKO) based on a monoclonal antibody was not included in the study. 
Materials and Methods 
Serum samples tested in this study were collected as part of the National Animal 
Health Monitoring System (NAHMS) Swine 2000 survey. Producers were allowed to submit 
up to 15 samples from finishing pigs and up to 30 samples from breeding age gilts and sows. 
Growing/finishing pigs older than 20 weeks and sows or gilts introduced into the breeding 
herd were eligible to be tested. Serum samples from boars and nursery aged pigs were not 
included in the survey. Detailed information about sample collection and survey 
methodology is available in several NAHMS Swine 2000 reports. 33 , 60, 61 
Serum samples were tested for antibodies to M. hyopneumoniae by the Tween 20 
ELISA17 at Iowa State University, and a commercially available ELISA (IDEXX HerdChek 
M. hyo) at Boehringer Ingelheim Animal Health, Ames, Iowa. 
The NAHMS survey collect 14,092 serum samples from swine herds across the 
United States. A total of 64 7 samples were eliminated due to unresolved questions about 
origin and sample handling. 
The kappa coefficient is a method of determining agreement between observers (tests 
in this case) beyond that of chance. It should be noted that the kappa coefficient measures 
the strength of agreement between tests; it does not provide a comparison to a gold standard 
or known disease status. Therefore, two assays may have a high level of agreement (high 
kappa score), but be equally poor at detection of disease or correctly classifying negative 
animals. The two assays were evaluated with the kappa coefficient using published 
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benchmarks. 57 Where a kappa value = 0 is classified as poor agreement; kappa values from 
0.01 - 0.20 constitute slight agreement; kappa values from 0.21 - 0.40 constitute fair 
agreement; kappa values from 0.41 - 0.60 constitute moderate agreement; kappa values from 
0.61 - 0.80 constitute substantial agreement; and kappa values 2: 0.81 constitute perfect 
agreement. Statistical analyses were performed using SAS v8.02 (SAS, Inc., Cary, NC). 
Results 
Table 4.1 presents the kappa coefficients for the two tests. The tests were compared 
for all samples, for finishing aged animals and for breeding sows and gilts. 
Both the Tween 20 ELISA and the HerdChek ELISA consider samples "suspect" 
when the OD value or SIP ratio falls into certain ranges. The suspect classification can 
present difficulty in interpretation of test results. In this study, suspect samples were treated 
in three ways and and statistically analyzed for each variation. Suspect samples were either 
eliminated, or classified as negative or changed. Table 1 shows the results for each of these 
categories for each class of animals (grow finish pigs comnpared to sows). 
The kappa coefficient determined the agreement between the tests to be in the 
moderate category, and none of the 95% confidence intervals for the coefficients fell outside 
the moderate category. Removing suspect samples from the calculation resulted in higher 
kappa coefficients than did changing the suspect sample classification to either positive or 
negative, however, kappa values remained in the moderate category. Suspect samples that 
were changed to positive or negative resulted in very close kappa values for those categories. 
The SIP ratios of the samples were examined based on the correlation between the 
two assays. The correlation between assays was greater when suspect samples were 
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excluded than when suspect samples remained in the equation as either positive or negative. 
Finisher samples had the highest correlation of SIP ratios, while sow and gilt samples had the 
lowest SIP ratio correlation. 
Discussion 
The Tween 20 and the HerdChek® ELISA used in this sutdy are similar indirect 
ELISAs, both using whole cell antigen preperations. As expected, it was found that the 
relative accuracy of the assays in this study remained fairly constant across a variety of ages 
and levels of disease prevalence. Estimated kappa values measuring the test agreement 
remained in the moderate category, regardless of the treatment of suspect samples. This was 
a consistent finding in the grower/finisher, breeding female and combined grower/finisher 
and breeding female populations. The findings presented in this study confirm that the two 
indirect ELISAs perform nearly identically across a variety of populations. 
Further analysis of the data for 
This study is limited in that the true infection status of the animals being tested for 
antibodies to M. hyopneumoniae is unknown. This makes it difficult to compare the two 
assays with a known gold standard. The study does reveal that the assays perform similarly. 
Without a known disease status to compare to, assesing adjustments to cut-off ponts is 
difficult. The stregnths of this study are the large number of samples involved, from a large 
geographical area, including a variety of populations in diverse production settings. 
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positives in other classes of samples, although this difference was not statistically significant. 
A larger study comparing the three assays would be beneficial to determine ifthere was a 
true difference between the DAKO® and the two indirect ELISAs in their ability to detect M 
hyopneumoniae antibodies. 
This study is also limited in that the true infection status of the animals being tested 
for antibodies to M. hyopneumoniae is unknown. Therefore, it was not possible to compare 
the results of the two assays with a known infection status. Without a known disease status 
to compare to, assessing adjustments to cut-off points is difficult. 
The strengths of this study are the large number of samples, obtained from a large 
geographical area. Samples were collected from a wide variety of management and 
production settings. 
There is further exploration of the NAHMS M hyopneumoniae serum testing that can 
provide useful information. Future analysis may include comparing the seroprevalence of 
antibodies to M hyopneumoniae by assay, assessing the management strategies as risk 
factors to seropositivity, and quantifying the relationship between the vaccination status of 
the animals and seropositivity. Another goal for future work in this area would be the 
elucidation of methods to quantitatively classify the M hyopneumoniae status of a herd based 
on ELISA results. 
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Tables 
T bl 4 1 B d. a e . : ree mg an d fi . h . mis mg amma s, a 11 1 . 1 d d samp es me u e 
HerdChek 
positive suspect negative 
Tween 20 positive 4216 443 1056 5715 
suspect 440 217 368 1025 
negative 1342 597 4766 6705 
5998 1257 6190 13445 
T bl 4 2 B d" a e . : ree mg an d fi . h. mis mg amma s, suspec samp es ex eluded. 
HerdChek 
positive negative 
I Tween 20 I positive 4216 1056 5272 
I negative 1342 4766 6108 
5558 5822 11380 
T bl 4 3 B d. a e . : ree mg an d fi . h. h mis mg amma s, suspect c ange to d positive. 
HerdChek 
positive negative 
I Tween 20 I positive 5316 1424 6740 I 
I negative 1939 4766 6705 I 
7255 6190 13445 
T bl 4 4 B d" a e : ree mg an d fi . h. mis mg amma s, suspec samp es c hanged to negative. 
HerdChek 
positive negative 
I Tween 20 I positive 4216 1499 5715 
I negative 1782 5948 7730 
5998 7447 13445 
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Finisher samples 
T bl 4 5 F' . h a e . : 1ms er samp es, a 11 I . I d d samp es me u e . 
HerdChek 
positive suspect negative 
Tween 20 positive 2091 154 459 
suspect 152 53 102 
negative 575 217 1821 
2818 424 2382 
T bl 4 6 p · . h a e . : mis er samp es, suspect samp es exc u e I d d 
HerdChek 
positive negative 
I Tween 20 I positive 2091 459 2550 
I negative 575 1821 2396 
2666 2280 4946 
T bl 4 7 p· . h h a e : mis er samp es, suspect samp es c ange d t ve. to pos1 1 
HerdChek 
positive negative 
I Tween 20 I positive 2450 561 3011 
I I negative 792 1821 2613 
3242 2382 5624 
2704 
307 
2613 
5624 
T bl 4 8 p· . h a e : mis er samp es, suspect samp es c ange h d to negat ive. 
HerdChek 
positive negative 
I Tween 20 I positive 2091 613 2704 
I negative 727 2193 2920 
2818 2806 5624 
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T bl 4 9 B d. a e . : ree mg amma s, a II I . I d d samp es me u e . 
HerdChek 
positive suspect negative 
Tween 20 positive 2125 289 597 3011 
suspect 288 164 266 718 
negative 767 380 2945 4092 
3180 833 3808 7821 
T bl 4 10 B d' a e . : ree mg amma s, suspect samp es exc u e I d d 
HerdChek 
positive negative 
I Tween 20 I positive 2125 597 2722 
I negative 767 2945 3712 
2892 3542 6434 
T bl 4 11 B d. h a e . : ree mg amma s, suspec samp es c ange dt o pos itive. 
HerdChek 
positive negative 
I Tween 20 I positive 2866 863 3729 
I negative 1147 2945 4092 
4013 3808 7821 
T bl 412 B d ' h a e . : ree mg amma s, suspect samp es c ange d to neg ative . 
HerdChek 
positive negative 
I Tween 20 I positive 2125 886 3011 
I negative 1055 3755 4810 
3180 4641 7821 
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Table 4.13: Kappa Values for Tween 20 and HerdChek® ELISA Comparison 
All Samples kappa (95% CI for kappa) Classification 
Suspect Samples Excluded 0.5778 (0.5629-0.5928) moderate 
Suspect Samples Regarded as Positive 0.4996 (0.4850-0.5142) moderate 
Suspect Samples Regarded as Negative 0.5039 (0.4892-0.5186) moderate 
Finisher Samples kappa (95% CI for kappa) Classification 
Suspect Samples Excluded 0.5809 (0.5582-0.6036) moderate 
Suspect Samples Regarded as Positive 0.5136 (0.4911-0.5361) moderate 
Suspect Samples Regarded as Negative 0.5235 (0.5013-0.5458) moderate 
Sow Samples kappa (95% CI for kappa) Classification 
Suspect Samples Excluded 0.5693 (0.5491-0.5895) moderate 
Suspect Samples Regarded as Positive 0.4866 (0.4673-0.5059) moderate 
Suspect Samples Regarded as Negative 0.4814 (0.4615-0.5012) moderate 
Table 4.14: Correlation of Tween 20 and HerdChek® ELISAs for categorical classification and s/p ratio. 
All Samples 
All Samples as reported 
Suspect Samples Excluded 
Suspect Samples Regarded as Positive 
Suspect Samples Regarded as Negative 
Finisher Samples 
All Samples as reported 
Suspect Samples Excluded 
Suspect Samples Regarded as Positive 
Suspect Samples Regarded as Negative 
Sow Samples 
All Samples as reported 
Suspect Samples Excluded 
Suspect Samples Regarded as Positive 
Suspect Samples Regarded as Negative 
r2 (p) 
0.536 (<0.0001) 
0.579 (<0.0001) 
0.501 (<0.0001) 
0.504 (<0.0001) 
r2 (p) 
0.548 (<0.0001) 
0.582 (<0.0001) 
0.515 (<0.0001) 
0.524 (<0.0001) 
r2 (p) 
0.521 (<0.0001) 
0.570 (<0.0001) 
0.488 (<0.0001) 
0.482 (<0.0001) 
sip ratio r2 
0.602 (<0.0001) 
0.623 (<0.0001) 
sip ratio r2 
0.632 (<0.0001) 
0.648 (<0.0001) 
sip ratio r2 
0.560 (<0.0001) 
0.587 (<0.0001) 
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CHAPTER 5: SUMMARY AND CONCLUSIONS 
The use of ELISAs to detect M. hyopneumoniae antibodies in swine serum is 
a common diagnostic assay in the field. The performance of M. hyopneumoniae ELISAs is 
not well documented in the current literature, especially concerning the performance on 
vaccinated animals and animals in the early stages of infection. This thesis compared the 
ability of three ELISAs to detect antibodies to M. hyopneumoniae in the serum of swine 
experimentally or naturally infected with the organism. 
The Tween 20 and the HerdChek® ELISA used in this study are similar indirect 
ELISAs. Both assays use whole cell antigen preparations of M hyopneumoniae for the 
detection of antibodies to the organism in serum. Since both assays use the same biological 
principles to detect antibodies, we expected them to perform similarly. In contrast, the 
DAKO® assay is a blocking ELISA using a monoclonal antibody to detect M. 
hyopneumoniae antibodies. The use of the monoclonal antibody theoretically reduces the 
potential cross reaction with antibodies induced by infection with other porcine 
mycoplasmas. 
The study described in chapter three found the DAKO® ELISA to be superior in 
detecting antibodies to M. hyopneumoniae early after experimental infection. This difference 
was statistically significant compared to the Tween 20 ELISA, but not statistically significant 
compared to the HerdChek® ELISA. The DAKO® ELISA was not found to be statistically 
different from the Tween 20 ELISA or the HerdChek® ELISA in the other classes of 
samples tested. This lack of significance may be due to the small number of samples used in 
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that study. Repeating the study with a larger number of samples would further quantify the 
differences between the assays. 
All three of the assays evaluated had excellent specificities, correctly identifying 
negative samples. The sensitivity of the assays determined in this study was found to be 
lower than desirable for individual diagnosis of infection. It should be noted that the low 
sensitivities found are not necessarily indicative of poor quality of the tests, but rather the 
variable and often delayed immune response generated by M hyopneumoniae. Studies with 
lasting longer than 28 days post infection would be beneficial to further quantify the 
serological reaction to M hyopneumoniae and test properties for detection of infection by 
serum testing. 
The study described in chapter four compared the performance of the Tween 20 and 
HerdChek® ELISAs and found them to be fairly consistent across a variety of ages and 
levels of disease prevalence. Based on these findings, the HerdChek® and Tween 20 assays 
have similar performance characteristics over a large number of samples from a variety of 
populations. 
This study is also limited in that the true infection status of the animals being tested 
for antibodies to M. hyopneumoniae is unknown making it impossible to compare the results 
of the two assays with a gold standard. Without a known disease status to compare to, 
assessing adjustments to cut-off points becomes more difficult. The strengths of this study 
include the large number of samples obtained from an extensive geographical area and a 
wide variety of management and production settings. 
Future analysis of the NAHMS Swine 2000 survey data may include comparing the 
seroprevalence of antibodies to M hyopneumoniae by assay, assessing management 
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techniques as risk factors to seropositivity, and quantifying the relationship between the 
vaccination status of the animals and seropositivity. Another goal for future work in this area 
would be the elucidation of methods to quantitatively classify the M. hyopneumoniae status 
of a herd based on ELISA results. 
Further studies in the area of diagnostic testing for M hyopneumoniae should include 
areas such as further qualification of the low sensitivities of the ELISAs, and what measures 
can be used to improve the sensitivities. A comparison of the ELISAs to modem diagnostic 
techniques such as nested PCR on nasal swabs is also warranted. 
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APPENDIX: LIST OF ABBREVIATIONS 
ADG: Average Daily Gain 
APP: Actinobacillus pleuropneumoniae 
EP: Enzootic Pneumonia 
ELISA: Enzyme Linked Immunosorbant Assay 
FC: Feed Conversion 
IHA: Indirect Hemagglutination Assay 
IHC: Immohistochemistry 
IIF: Indirect Immunoflourescent Assay 
PCV2 Porcine Circovirus 2 
MPS: Mycoplasmal Pneumonia of Swine 
PMWS: Post Weaning Multi-systemic Wasting Disease 
PRRS: porcine reproductive and respiratory syndrome 
PRRSV: porcine reproductive and respiratory syndrome virus 
NAHMS: National Animal Health Monitoring System 
SDS: Sodium Dodecyl Sulfate 
SEP: Swine Enzootic Pneumonia 
SIV: Swine Influenza Virus 
SPF: Specific Pathogen Free 
